28 Jan 2010
AstraZeneca - Q4 and full year results 2009
You need Adobe Flash player to view this content.
You can download it the flash player here
Now playing
David Brennan, CEO, AstraZeneca
Video sections
- R&D changes03:06
- Restructuring programme01:14
- Strategy04:09
- Drug portfolio02:28
- Outlook02:27
Past performance should not be seen as an indication of future performance.
By viewing the video or accessing the transcript you are agreeing to accept the Cantos Terms and Conditions.
Watch more Health Care
-
GLAXOSMITHKLINE
07 Feb 2012
GlaxoSmithKline - Q4 and full year results 2011 -
ASTRAZENECA
02 Feb 2012
AstraZeneca - Q4 and full year results 2011 -
CONSORT MEDICAL
01 Dec 2011
Consort Medical - Half year results 2011 -
BTG
17 Nov 2011
BTG - Half year results 2011 -
OXFORD BIOMEDICA
31 Aug 2011
Oxford BioMedica - Half year 2011 results -
HIKMA PHARMACEUTICALS
25 Aug 2011
Hikma - Half year results 2011 -
AXIS-SHIELD
24 Aug 2011
Axis-Shield - Half year results 2011 -
SMITH AND NEPHEW
05 Aug 2011
Smith and Nephew - Half year results 2011
Also on Cantos
- 24 Aug 2011
Just how safe is the dollar-Swiss franc safe haven? - 23 Aug 2011
FTSE 'more bouncing around' - 21 Aug 2011
FTSE downside target - and it could go lower - 18 Aug 2011
Selling pressure to temper oil's gains - 17 Aug 2011
Gold, silver to lose momentum?
